Cardiol Therapeutics Inc. (CRDL) Financials

CRDL Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 31.7 million 6.0 million
2023-06-30 35.6 million 6.4 million
2023-03-31 38.9 million 5.3 million
2022-12-31 45.7 million 7.2 million

CRDL Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -2.5 million 1.5 million
2023-06-30 -4.0 million 503398
2023-03-31 -7.4 million 315484
2022-12-31 -6.6 million 699078

CRDL Net Income

No data available :(

CRDL Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 29.8 million - 133332
2023-06-30 33.9 million - 36405
2023-03-31 36.6 million - 44838
2022-12-31 43.9 million - 53739

CRDL Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 47.5 million
2023-06-30 48.4 million
2023-03-31 47.4 million
2022-12-31 47.2 million

CRDL Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 4103 1.9 million 3.7 million -
2023-06-30 2939 2.6 million 2.1 million -
2023-03-31 32624 3.1 million 2.7 million -
2022-12-31 35272 4.1 million 2.6 million -

CRDL Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 47748
2023-06-30 - 44187
2023-03-31 - 43022
2022-12-31 - 42797

CRDL

Price: $1.98

52 week price:
0.51
2.17

Earnings Per Share: -0.32 USD

P/E Ratio: -3.37

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 88200

Market Capitalization: 125.4 million

Links: